Serial #79378834
LIVE

Serial Number

79378834

Owner

BRISTAR IMMUNOTECH LIMITED

Attorney

Nazly Aileen Bayramoglu

Filing Date

May 4, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79378834 Trademark

Serial Number: 79378834 • Registration: 7602246

Serial #79378834 is a trademark filed by BRISTAR IMMUNOTECH LIMITED on May 4, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

BRISTAR IMMUNOTECH LIMITED (3 trademarks)

Room 501, 5th floor, Building No. 1,

Entity Type: 99

Trademark Details

Filing Date

May 4, 2023

Registration Date

December 17, 2024

Published for Opposition

October 29, 2024

Goods & Services

Technological research in the field of evaluation of efficiency and safety of medication; conducting technical project studies in the field of evaluation of efficiency and safety of medication; scientific laboratory services; scientific research; chemical analysis; chemical research; biochemical research and analysis; medical and scientific research, namely, conducting clinical trials for others; biological research

medicines for human purposes for the treatment of cancer, hematological tumors, solid tumors, autoimmune diseases, and regulation of the immune system; pharmaceutical preparations for the treatment of cancer, hematological tumors, solid tumors, autoimmune diseases, and regulation of the immune system; drugs for medical purposes, namely, medicines for the treatment of cancer, hematological tumors, solid tumors, autoimmune diseases, and regulation of the immune system; blood for medical purposes; biological preparations for medical purposes for the treatment of cancer, hematological tumors, solid tumors, autoimmune diseases, and regulation of the immune system; stem cells for medical purposes; immunostimulants; injectable medicinal solutions, namely, medicinal preparations for the treatment of cancer, tumors, autoimmune diseases, and regulation of the immune system; biochemical medicines for the treatment of cancer, tumors, autoimmune diseases, and regulation of the immune system; Blood products, namely, blood plasma

Import-export agency services; marketing; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale store services featuring medicines; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring sanitary preparations; retail and wholesale store services featuring medical supplies

T-cell treatment therapy services; blood bank services; human tissue bank services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; hospital services; medical clinic services; medical assistance; telemedicine services; nursing, medical; health care

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 21, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 28, 2025 FICS
FINAL DISPOSITION PROCESSED
May 28, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 17, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 1, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 12, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 12, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 29, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 29, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 9, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 21, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 21, 2024 TROA
REFUSAL PROCESSED BY IB
Mar 19, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 28, 2024 RFCS
REFUSAL PROCESSED BY MPU
Feb 28, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 7, 2024 RFCR
NON-FINAL ACTION WRITTEN
Feb 6, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 30, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 23, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 19, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 14, 2023 REPR